Natco Pharma informs about press release

02 Jul 2018 Evaluate

Natco Pharma has informed about press release titled, 'NATCO launches fixed dose combination of Sofosbuvir-Daclatasvir drug for Hepatitis C treatment in INDIA'.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

812.35 -19.40 (-2.33%)
27-Jan-2026 15:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1640.00
Dr. Reddys Lab 1239.85
Cipla 1314.65
Zydus Lifesciences 893.20
Lupin 2146.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×